| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/21/2006 | EP1670903A2 Treatment of neurodegenerative diseases |
| 06/21/2006 | EP1670896A2 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 06/21/2006 | EP1670827A2 Anti-ghrelin antibodies |
| 06/21/2006 | EP1670826A1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 06/21/2006 | EP1670823A1 Chimeric mhc protein and oligomer thereof for specific targeting |
| 06/21/2006 | EP1670822A2 Igf binding proteins |
| 06/21/2006 | EP1670820A2 Antigens for an east coast fever vaccine |
| 06/21/2006 | EP1670818A2 Piscirickettsia salmonis antigens and use thereof |
| 06/21/2006 | EP1670817A2 Uses of spatial configuration to modulate protein function |
| 06/21/2006 | EP1670811A2 Shc proteins as therapeutic targets in proliferative diseases |
| 06/21/2006 | EP1670810A2 Gapped oligomeric compounds having linked bicycli csugar moieties at the termini |
| 06/21/2006 | EP1670779A2 Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol |
| 06/21/2006 | EP1670518A1 Rna interference for the treatment of gain-of-function disorders |
| 06/21/2006 | EP1670517A1 Lentiviral apoe2 gene therapy |
| 06/21/2006 | EP1670511A2 Cripto antagonism of activin and tgf-b signaling |
| 06/21/2006 | EP1670508A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 06/21/2006 | EP1670505A2 Dna promoters and anthrax vaccines |
| 06/21/2006 | EP1670428A2 G-csf transferrin fusion proteins |
| 06/21/2006 | EP1670425A2 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 06/21/2006 | EP1670415A2 Animal model for protease activity and liver damage |
| 06/21/2006 | EP1670309A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 06/21/2006 | EP1670308A1 Chimeric cancer models |
| 06/21/2006 | EP1670307A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 06/21/2006 | EP1629095A4 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 06/21/2006 | EP1587941A4 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 06/21/2006 | EP1581642A4 Genes conferring herbicide resistance |
| 06/21/2006 | EP1565053A4 Compositions and methods for altering tocotrienol content |
| 06/21/2006 | EP1534858A4 Methods and compositions for monitoring primer extension and polymorphism detection reactions |
| 06/21/2006 | EP1504106A4 Method of increasing plant organ and seed size in a plant |
| 06/21/2006 | EP1482803A4 Plant preparations |
| 06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
| 06/21/2006 | EP1461452A4 Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions |
| 06/21/2006 | EP1451352A4 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis b viral dna |
| 06/21/2006 | EP1410023B1 Methods using o6-alkylguanine-dna alkyltransferases |
| 06/21/2006 | EP1390531B1 Quantitative diagnostic analysis of predisposition to hypertension |
| 06/21/2006 | EP1326895B8 Monoclonal antibodies directed against hepatitis b viruses |
| 06/21/2006 | EP1297151B1 14911 novel protein kinase molecules and uses therefor |
| 06/21/2006 | EP1255816B1 Tailored peptide synthetases, a method for their production and the use thereof |
| 06/21/2006 | EP1252315B1 Method for the production of a protein |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1183393B1 Pcr-based identification of eimeria species and strains |
| 06/21/2006 | EP1171583B1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 06/21/2006 | EP1137790B1 An improved efficiency agrobacterium-mediated plant transformation method |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0994964B1 Detection of nuceic acids by multiple sequential invasive cleavages |
| 06/21/2006 | EP0975806B1 Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr) |
| 06/21/2006 | EP0934416B1 Feline polynucleotide vaccine formula |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0923600B1 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/21/2006 | EP0853676B1 Seed shattering |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0778888B1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | EP0723663B1 Hybridoma and anti-kc-4 humanised monoclonal antibody, dna and rna encoding it, kit and diagnostic methods |
| 06/21/2006 | CN1791875A Method for designing DNA codes used as information carrier |
| 06/21/2006 | CN1791683A Markers for LXR activation |
| 06/21/2006 | CN1791679A Gene therapy vectors having reduced immunogenicity based on CD8 alpha-chain |
| 06/21/2006 | CN1791678A Improved alphavirus replicons and helper constructs |
| 06/21/2006 | CN1791677A Expression of desirable proteins in plant roots and cell cultures |
| 06/21/2006 | CN1791676A Method for the preparation of transgenic plants characterised by geminivirus lasting resistance |
| 06/21/2006 | CN1791675A Viral vectors expressing fusion of viral large envelope protein and protein of interest |
| 06/21/2006 | CN1791674A Functional characterization of myo-inositol monophosphatase |
| 06/21/2006 | CN1791673A Improved transformant and process for producing polyester using the same |
| 06/21/2006 | CN1791672A Subtilases |
| 06/21/2006 | CN1791671A Method of screening for target ligands |
| 06/21/2006 | CN1791668A Preparation of endodermal stem cells |
| 06/21/2006 | CN1791421A Method for inducing mammary epithelial cell differentiation |
| 06/21/2006 | CN1789424A Dual target effected chimera recombinant, its construction method and application |
| 06/21/2006 | CN1789423A Determination and application of hepatitis C virus specific cDNA sequence |
| 06/21/2006 | CN1789422A PNZIP promotor sequence, its clone and application |
| 06/21/2006 | CN1789421A Wheat WRAB 17 gene promotor and application thereof |
| 06/21/2006 | CN1789420A Wheat WCOR726 gene promotor and application thereof |
| 06/21/2006 | CN1789419A Wheat WRAB19 gene promotor and application thereof |
| 06/21/2006 | CN1789418A Amylopectase type starch debranching enzyme gene promoter and its application |
| 06/21/2006 | CN1789417A Method for quickly separating target chromosome expressed sequence |
| 06/21/2006 | CN1789416A Human artificial chromosome containing human antibody lambda light chain |
| 06/21/2006 | CN1789415A Recombined aquatic bird flu virus H5 subtype hemagglutinin, its preparation method and uses |
| 06/21/2006 | CN1789412A Reconstruction of 5-enol pyruvoyl shikimic acid-3-phosphate synthetase activity by utilizing fragment complementation technique |
| 06/21/2006 | CN1789411A Isolated nucleic acid molecules which encode T cell inducible factors (TIF), the proteins encoded, and uses thereof |
| 06/21/2006 | CN1789284A Human interleukin 8 antagonist protein and preparation method thereof |
| 06/21/2006 | CN1789282A Multifunctional polypeptide |
| 06/21/2006 | CN1789281A Synthesis method of 3 beta protein of pig ovum pellucid zone |
| 06/21/2006 | CN1789280A PHD transcription factor of soybean and its coding gene and usage |
| 06/21/2006 | CN1789276A One-step purification method of recombined human osteogenesis protein -1 |
| 06/21/2006 | CN1260570C Process for preparing kit for the diagnosis of SARS |
| 06/21/2006 | CN1260367C Fortified fusion protein possessing angiopoiesis-inhibiting and anti-tumour actions |
| 06/21/2006 | CN1260363C Novel nitrile hydratase |
| 06/21/2006 | CN1260362C Method for separating and identifying flower pesticide specific promoter of cotton |
| 06/21/2006 | CN1260361C Inhibition of Ii synthesis |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/21/2006 | CN1260359C High-solublity expressed tricholsanthin mutant and its preparing method |
| 06/21/2006 | CN1260358C cDNA segment of controlling growth of microspore of paddy, coded result and application |
| 06/21/2006 | CN1260357C Improved anti-IgE antibodies and method of improving polypeptides |
| 06/21/2006 | CN1260356C Recombinant gene of soluble part in cytolytic T cell relative antigen 4 and its fusion gene and product |
| 06/21/2006 | CN1260352C Self-coagulating producing hydrogen bacteria |
| 06/21/2006 | CN1260351C Streptomyces antifungus |
| 06/21/2006 | CN1260350C Nocardia alba |
| 06/21/2006 | CN1260349C Streptomyces nanningensis |
| 06/21/2006 | CN1260348C Kribbella antibiotica |
| 06/21/2006 | CN1260347C Hydantoin enzyme series-producing anthrobacter |